Abstract: Historically, recruitment of minority subjects for clinical research has been challenging. We developed culturally-tailored recruitment materials for a longitudinal, natural history study of intracerebral hemorrhage (ICH) and trained recruiting coordinators in cultural competence. Of 285 subjects meeting inclusion criteria, 158 (55% of those eligible) agreed to participate (60% of eligible Blacks vs. 45% of eligible non-Blacks, p.02). Of those enrolled, 138 (87%) agreed to participate in the genetic sub-study (86% of Blacks vs. 90% of non-Blacks enrolled, p.78). Of those subjects who refused enrollment, lack of interest in research (42%) was the most common reason given for the study as a whole. A higher rate of enrollment was achieved in Blacks vs. non-Blacks in this ICH clinical research study employing culturally tailored recruitment approaches and training of recruitment coordinators to overcome traditional recruitment barriers to research participation in minority patients.
R ecruitment of research participants is essential for successful clinical and translational research. 1 Studies that fail to achieve planned enrollments are unable to support planned hypothesis-testing, thus compromising scientific relevance and generalizability. A recent evaluation of federally sponsored oncology trials showed that more than 25% failed to achieve minimum recruitment goals. 2 Even fewer clinical studies achieve adequate representation of underrepresented minorities. [3] [4] [5] Historically, researchers have found that Black patients are significantly less likely than Whites to participate in clinical research, particularly research involving biomarkers such as neuroimaging or genetic studies. [6] [7] [8] These low rates of participation limit the exploration of specific racial and ethnic differences in diseases and delay the development of more effective prevention and treatment strategies. Several factors have been associated with these low rates of minority participation, including that of Blacks, in biomedical research. First, potential Black subjects may be approached for enrollment less frequently. 9, 10 Second, distrust of research and lack of access to medical care have also been associated with low rates of research participation.
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A number of studies have documented the effects of sociological and attitudinal factors such as discrimination, access to care, distrust of the medical community, suspicion of genetic testing, and dislike of the research process. All these factors may affect willingness of minorities, including Blacks, to participate in clinical studies. [11] [12] [13] Recently, there has been a growing awareness of the importance of minority participation in clinical research.
14 However, few studies have specifically examined and/or reported their recruitment experience, particularly in diseases such as stroke that disproportionately affect minority populations.
Intracerebral hemorrhage (ICH) is a devastating disease with poor prognosis and high mortality rates ranging from 25-50%. 15 Intracerebral hemorrhage is the underlying etiology in 10-15% of all strokes with 75% of those being due to primary (nontraumatic) hemorrhage. Population-based studies have consistently demonstrated that primary ICH is significantly more frequent in underserved populations. 16 The DiffErenCes in the Imaging of Primary Hemorrhage based on Ethnicity or Race (DECIPHER) study is a National Institutes of Health (NIH) funded study designed to investigate whether racial/ethnic differences exist in the underlying risk factors, pathogenesis, and imaging appearance of primary ICH in a predominantly underserved Black population. We examined recruitment rates by race, as well as reasons for recruitment or refusal, for subjects enrolled to date in this ICH natural history project and its genetic substudy.
methods
Study design. In the DECIPHER study, patients with primary ICH are enrolled and followed for up to four years. Inclusion criteria are primary ICH within 30 days of onset, age 18 years old or younger, and signed informed consent obtained from the patient or patient's legally authorized representative. Patients with any of the following are excluded: contraindication to magnetic resonance imaging (MRI), pregnancy, central nervous system (CNS) tumor or active infection or inflammatory process, CNS arteriovenous malformation, CNS aneurysm, CNS trauma within prior two weeks, craniotomy/craniectomy for current ICH, international normalized ratio (INR) 3.
Patients undergo clinical assessments, MRI, and neuropsychological evaluations at enrollment, 30 days, one year and three years. Brief clinical assessments are performed by phone at two years and four years. Subjects are also approached for participation in a genetic substudy that includes testing of Aopolipoprotein E (APOE) status. The APOE gene is associated with increased risk of intracerebral hemorrhage. Although subjects of all races and ethnicities are enrolled, we limited the current analysis to Black vs. non-Black subjects, as there are too few subjects of other races/ethnicities to perform a meaningful analysis or comparison. Moreover, our focus in the current analysis is to explore differences in Blacks vs. other races in recruitment rates.
Study recruitment. All patients admitted with a primary diagnosis of ICH admitted to five hospitals in the greater Washington, D.C. region were screened for eligibility. All recruitment coordinators for the DECIPHER project receive training in cultural competence and all materials are culturally tailored. A number of recruitment strategies have been employed: 1) design of inclusive brochures and written materials at the appropriate literacy level (6th grade), 2) ongoing education of coordinators regarding historical factors that may have contributed to distrust of research as well as disparities in health care, 3) adoption of social marketing strategies addressing social and cultural factors that may affect individual beliefs and behaviors, 4) planned multiple approaches to patients and families, 5) coordinator training in immediately addressing concerns identified by potential subjects. All recruitment materials were reviewed by the community advisory board and materials were modified as appropriate based on their suggestions. Concerns raised by potential participants included cost of participation, loss of privacy, whether family members could provide informed consent and claustrophobia in the MRI scanner.
For all patients eligible for the DECIPHER study, we systematically record reasons for participation or refusal for the overall study as well as reasons for refusal of the genetic sub-study. Data are systematically recorded after each encounter in a structured screening/recruitment log including the number of approaches or interactions, the person approached (patient or proxy), and stated reason for enrollment or refusal. The recruitment log was designed as a one-page checklist to facilitate documentation of recruitment activities. The list of reasons for enrollment or refusal was drawn from documentation created for a previous stroke study conducted in an acute care setting. The recruitment log data were reviewed weekly by the study coordinators and investigators. Box 1 lists the various options for reasons for enrollment or refusal for the overall study and the reasons for refusal for the genetic sub-study.
The main outcome of the analysis is the percentage of eligible participants who have enrolled to date in the main study and the genetic sub-study. Secondary outcomes include the reasons given for participation or refusal.
analysis. Dichotomous variables were analyzed using Pearson chi-square or Fisher's exact test as appropriate. Student's t test was used to analyze mean differences of continuous variables between groups. All analyses were computed using SPSS Version 20. 17 results Figure 1 provides a flow chart of screened and enrolled patients. At the time of the current analysis, a total of 892 patients with possible primary ICH had been screened for enrollment in the DECIPHER project. Of these, 417 met inclusion criteria, however, 131 were not able to give consent (e.g., patient discharged prior to consent, no legally authorized representative reachable). The remaining 286 patients were approached and asked to participate in the study. One hundred and fifty eight agreed to participate (55%), and 128 refused (47%). The demographic characteristics of the study participants and the individuals who refused participation are presented in Table 1 . Study participants are significantly younger (p.005) and more likely to be Black (p.04). There were no gender differences (p.1). For the overall study, 60% of eligible Blacks vs. 47% of eligible non-Blacks, (p.04) were enrolled (Figure 1) .
Of the 158 who consented: 56% were male, 75% were Black, mean baseline National Institutes of Health Stroke Scale (NIHSS) was 9 (median 5), and mean baseline MRI ICH volume was 25 cc (median 14 cc). One hundred thirty-eight (87%) of the 158 enrolled participants also consented to the genetic sub-study: 102 of the 118 Blacks (86%) vs. 36 of the 40 non-Blacks enrolled (90%), p0.78) (Figure 1 ). The mean number of approaches required to obtain consent was three (range 1-11). For the patients enrolled, stated reasons for participation were: 1) to benefit others (79%), or 2) to benefit themselves (20%).
Figures 2 and 3 provide response frequencies for the reasons for refusal for otherwise eligible patients who could give consent or whose family could give consent. The three most common reasons were 1) lack of interest in research, 2) dislike of MRI, and 3) family refusal due to poor prognosis. The reasons for refusal did not appear to differ by race; however the sample is not large enough to statistically compare differences between the two groups. For the genetic sub-study, the three most common stated reasons for refusal were 1) family refusal due to discomfort with proxy consent process (33%), 2) family refusal due to patient's poor prognosis (22%), and 3) dislike of procedures/needles.
Discussion
Increased participation in biomedical research is essential to achieving health equity and to decreasing the burden of stroke and other chronic diseases on the Black community. Study investigators must not only be familiar with the reasons why Black participants are hesitant or unwilling to participate, but also must be able to use this information to address barriers to participation actively by tailoring in our study recruitment materials and research procedures. Study materials must clearly and directly link research participation to the development of new and more effective ways of reducing the impact of stroke in the Black community. Study coordinators also must be fully knowledgeable of study procedures and intended outcomes. They should be very comfortable answering questions and addressing concerns as part of the recruitment visit. Finally, study findings should be shared with participants and families as well as the general public so that the benefits of research participation can become more widely NIHSS  National Institutes of Health Stroke Scale known in communities with the greatest risk. Working with local media within the target community to disseminate study findings will help to raise awareness as well as increase interest in future studies.
In conclusion, we achieved greater rates of recruitment of Black patients compared with non-Blacks in this ICH study. Coordinator training in cultural competence, additional time and resources allocated to the recruitment process to allow for multiple contacts between the recruitment staff and patients and their families, along with trial materials specifically designed to increase trust likely contributed to the overall success of recruitment of Black subjects in the DECIPHER project. We also found that both Black and White subjects willing to participate in this natural history study were generally willing to participate in genetic research. However, distrust or dislike of research remains an important overall barrier to recruitment.
